BEAM Alliance and global partners call for urgent action on new reimbursement models for life-saving antibiotics
01 September 2020
The BEAM Alliance and the co-signatories of this paper urge the EU and its Member States to urgently act and fix the broken economics around investment into the development and commercialization of antimicrobials.
Further reading: BEAM Alliance
Author(s): BEAM Alliance
Smart Innovations
EADA 2023
Emerging Antimicrobials and Diagnostics in AMR 2023
International Matchmaking Symposium EADA 2023
Amsterdam, The Netherlands
16/17 November